Tue Feb 09, 2010
UCLA Kidney Cancer Program: Kidney Cancer Treatment and Research at UCLA in Los Angeles, CA Research and Education: David Geffen School of Medicine at UCLAPatient Care: UCLA Health System
UCLA Kidney Cancer Program: Kidney Cancer Treatment and Research at UCLA in Los Angeles, CA
Home
About Us
About Kidney Cancer
Treatment Options
Surgical Treatments
Tumor Ablation
Embolization
Immunotherapy
Targeted Therapy
Surveillance
Clinical Trials
Chemotherapy
Future Treatments
After Treatment
FAQ
Our Team
Donor Profiles
Clinical Trials
Education
News and Events
Contact Us
Request an Appointment
Help Fight Kidney Cancer
Helpful Links
Urology Department


 

Treatment Options / Clinical Trials

Clinical Trials-Treatment for Kidney Cancer

Research protocols, or clinical trials, are carefully controlled research studies in which cancer patients help doctors and scientists find ways to improve health and cancer care, and to make sure the treatments are safe and effective.

Clinical TrialsEach study is designed to address and answer specific scientific questions and to find better ways to prevent, diagnose or treat cancer. A clinical trial is one of the final stages resulting from the research conducted during intensive and lengthy laboratory studies. 

There are many promising non-standard therapies being studied in UCLA's Kidney Cancer Program, which include cellular immune therapy (dendritic cell therapy, autolymphocyte therapy, tumor infiltrating lymphocytes, etc), tumor vaccines, gene therapy, stem cell transplant, anti-angiogenesis therapy, inhibitors of growth factors, etc.

Although many of these therapies appear to be very promising, they are still experimental, and it is unclear whether or not they are effective treatments for kidney cancer. If you are interested in finding out more about these protocols, ask a member of the UCLA Kidney Cancer Program team about current trials being conducted at UCLA (See Ongoing Clinical Trials).